SSY GROUP (02005): Nifedipine has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketable preparations.

10/04/2025

GMT Eight

SSY GROUP (02005) announced that the group's Amlodipine has been approved by the China National Medical Products Administration for registration as a raw material for use in marketed formulations. Amlodipine is mainly used to treat mild to moderate essential hypertension, as well as stable angina. As stated in the company's announcement dated March 30, 2023, the group's Amlodipine/Amlodipine II sustained-release and controlled-release tablets (5mg) have been successful in the national centralized drug procurement bidding in China.

The Federal Reserve Hammack calmly watches as US Treasury yields rise: The US financial market is tense but still functioning.

Kaishan Group (300257.SZ) subsidiary KSOH obtains exclusive geothermal exploration rights in Hungary.

Contact: [email protected]

SSY GROUP (02005): Nifedipine has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketable preparations.

RECOMMEND

National Energy Administration: As of the end of March, the cumulative installed capacity of power generation in the country reaches 3.43 billion kilowatts, a year-on-year increase of 14.6%.

Guosen: Hong Kong stock market oscillates and repairs, funds flow into internet and finance sector.

"Second battlefield of trade negotiations"? Global Finance CKH HOLDINGS central bank governors gather in Washington, IMF/World Bank spring meetings to be held next week.